Your browser does not support scripts, this page will not display properly!
ISMP (US)
Contact Us
Feedback
Search:
ISMP Canada News
March 15, 2019:
Health Canada: Increased risk of blood clots and of death in rheumatoid arthritis patients on high dose of tofacitinib (Xeljanz)
Health Canada: Increased risk of blood clots and of death in rheumatoid arthritis patients on high dose of tofacitinib (Xeljanz)
Copyright © 2000-2016 Institute for Safe Medication Practices Canada (ISMP Canada). All Rights Reserved.
